Posted by Michael Wonder on 11 Oct 2022
ICER releases draft evidence report on treatment for vasomotor symptoms associated with menopause
11 October 2022 - Registration now open for October 19 “Early Insights” webinar.
The ICER today released a Draft Evidence Report assessing the comparative clinical effectiveness and value of fezolinetant (Astellas) for the vasomotor symptoms associated with menopause.
